| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22dac0df31985622b4c1a2ef109cc106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2019-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f5774b44e73e7d4e4e11be53d547f5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b73d7b1f56ecbcd3fbd2c3a213f978e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a1e9cad422516d8dd8fb4e240fead0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c876316b33e5e89b48ef90328c49b2a3 |
| publicationDate |
2020-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3677254-A1 |
| titleOfInvention |
Solid oral pharmaceutical compositions of desvenlafaxine |
| abstract |
The present invention relates to solid oral pharmaceutical compositions comprising desvenlafaxine or a pharmaceutically acceptable salt thereof which provides enhanced stability, wherein the composition is free of carrier. |
| priorityDate |
2018-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |